There are challenges aplenty in purification and analysis of PEGylated protein pharmaceuticals. Here are a variety of technical solutions, many concentrating on the chemistry of the linker.
Scott D. Buckel, Ph.D
Advertisement
Articles by Scott D. Buckel, Ph.D
Advertisement
Latest Updated Articles
Making Site-specific PEGylation WorkPublished: March 1st 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
